Post by Tony Chen | July 2, 2018 Monitor Suppliers Monitor Suppliers Categories Select category 483s 510(k) Aseptic Audit Prep Biopharma / Pharma CAPA CGMP Clinical Clinical Investigator CQO/SVP Quality/VP Quality Data Integrity Director/Manager QA Enforcement News Enforcement Trends FDA FDA Consent Decree FDA Warning Letters FDA-Regulated Industry FDAzilla Featured Food Audit Prep Food Supplier Quality FSMA GxP Consulting GxP Equipment and Software Vendors Highlighted Human Drugs Inspections Labeling Law Firm Medical Devices Misc. Drug Sourcing/Purchasing Monitoring MOST POPULAR Pharmacovigilance Quality Assurance Regulatory/Guidance Repeat Observations Supplier Management Validation Recent Posts August 14, 2019 AveXis’s New Gene Therapy Approved but New Questions Are Raised August 13, 2019 Week of August 4th, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies August 9, 2019 Part 2: Analysis of CY2018 FDA Warning Letters That Cite Data Integrity Failures Featured Post Post by FDAzilla | August 14, 2019 AveXis’s New Gene Therapy Approved but New Questions Are Raised
